Zusammenfassung
Die häufigste Komplikation von Heparinen, Vitamin-K-Antagonisten und Thrombozytenhemmern sind Blutungen. Bei Blutungskomplikationen oder bei einer dringlich indizierten invasiven/chirurgischen Intervention kann es notwendig werden, die Gerinnungshemmung aufzuheben.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Angiolillo DJ, Firstenberg MS et al. (2012) Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery JAMA 307:3
Crowther MA, Warkentin TE (2008) Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood 111: 4871–4879
Dentali F, Ageno W, Crowther M (2006) Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 4: 1853–1863
Deutsche Bundesärztekammer (2008) Querschnitts-Leitlinien (BÄK) zur Therapie mit Blutkomponenten und Plasmaderivaten, 4. Aufl. Deutscher Ärzte-Verlag, Köln
Ferrari E, Benhamou M, Cerboni P, Marcel B (2005) Coronary syndroms following aspirin withdrawal J Am Coll Cardiol 45: 45–6
Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293: 212–6
Kaatz S, Kouides PA, Garcia DA et al. (2012) Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol 87 Suppl 1: S141–145. Review 87(7): 748
Kozek-Langenecker SA (2011) Thrombosis prophylaxis with new anticoagulants: Routine and specific risk groups. Wien Med Wochenschr 161(3-4): 5–3
Link A, Girndt M, Selejan S et al. (2009) Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med 37(1): 105–111
Moscucci M, Fox KAA, Cannon CP et al. (2003) Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Eventa (GRACE). Eur Heart J 24: 181–5
ÖGARI (2013) Österreichische Gesellschaft für Anästhesiologie, Reanimation und Intensivmedizin. Empfehlungen der Arbeitsgruppe perioperative Gerinnung (AGPG). Anamnese-basierte
Gerinnungsabklärung vor OP 2013.pdf. http://www.oegari.at/arbeitsgruppe.asp?id=116> . Gesehen am 6 Nov 2013
Pabinger I, Brenner B, Kalina U et al. (2008) Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 6: 622–631
Savonitto S, D’Urbano M, Carocciolo M et al. (2010) Urgent surgery in patients with a recently implanted coronary drug - eluting stent: a phase II study of »bridging« antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 104: 285–291
Schaden E, Kozek-Langenecker SA (2010) Direct thrombin inhibitors: pharmacology and application in intensive care medicine. Intensive Care Med 36(7): 1127–1137
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wiedermann, C.J. et al. (2014). Blutung unter Antikoagulation und Thrombozytenhemmung. In: Fries, D., Streif, W. (eds) Gerinnungsmanagement in der Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-05004-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-05004-6_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05003-9
Online ISBN: 978-3-642-05004-6
eBook Packages: Medicine (German Language)